IP Library Assignment 069316/0760
Patent Assignment
Reel/Frame 069316/0760

Termination and Release of Security Interest

Recorded: 2024-11-11 Pages: 19
Assignor
Assignee
INDIVIOR UK LIMITED (F/K/A RB PHARMACEUTICALS LIMITED)
234 BATH ROAD, SLOUGH, BERKSHIRE, SLI 4EE, UNITED KINGDOM
Covered Properties (38)
Dehydrated Hydrogel Inclusion Complex of a Bioactive Agent with Flowable Drug Delivery System
Patent: 9,486,531 →
Application: 12/995,956 →
Publication: US 2011/0171305
Sustained Release Small Molecule Drug Formulation
Patent: 9,597,402 →
Application: 14/701,173 →
Publication: US 2015/0231258
Sublingual and Buccal Film Compositions
Application: 14/715,462 →
Publication: US 2015/0246005
Compositions to Alleviate Presystemic Metabolism of Opioids
Application: 14/781,683 →
Publication: US 2016/0051536
Sustained-Release Buprenorphine Formulations
Application: 14/935,168 →
Publication: US 2016/0128997
Sustained-Release Buprenorphine Solutions
Application: 15/125,052 →
Publication: US 2017/0079974
Dehydrated Hydrogel Inclusion Complex
Application: 15/295,630 →
Publication: US 2017/0035895
Injectable Composition Comprising Buprenorphine
Patent: 9,782,402 →
Application: 15/334,000 →
Publication: US 2017/0079976
Sustained Release Small Molecule Drug Formulation
Application: 15/422,626 →
Publication: US 2017/0239252
Sublingual and Buccal Film Compositions
Application: 15/483,769 →
Publication: US 2017/0209431
Therapeutic Compounds as Inhibitors of the Orexin-1 Receptor
Application: 15/508,392 →
Publication: US 2017/0291897
Dopamine D3 Receptor Antagonist Compounds
Application: 15/522,863 →
Publication: US 2017/0334895
Buprenorphine Dosing Regimens
Application: 15/523,986 →
Publication: US 2017/0354653
Injectable Flowable Composition Comprising Buprenorphine
Patent: 9,827,241 →
Application: 15/623,191 →
Publication: US 2017/0281618
SUBSTITUTED HEXAHYDROPYRROLO[3,4-b]PYRROLES AND HEXAHYDROCYCLOPENTA[c]PYRROLES AS DOPAMINE RECEPTOR MODULATORS
Application: 15/750,128 →
Publication: US 2018/0222918
Psychiatric Treatment for Patients with Gene Polymorphisms
Application: 15/763,777 →
Publication: US 2019/0046532
Dopamine D3 Receptor Antagonists Having a Morpholine Moiety
Application: 15/767,328 →
Publication: US 2018/0297990
Quantification of Drugs in Biological Samples
Application: 15/772,457 →
Publication: US 2018/0313858
Injectable Flowable Composition Comprising Buprenorphine
Application: 15/820,048 →
Publication: US 2018/0157440
Sustained-Release Buprenorphine Formulations
Application: 15/847,548 →
Publication: US 2018/0243292
Injectable Flowable Composition Comprising Buprenorphine
Application: 15/857,507 →
Publication: US 2018/0121137
Sustained Delivery Formulations of Risperidone Compound
Application: 15/858,525 →
Publication: US 2018/0154001
Intranasal Naloxone Compositions and Methods of Making and Using Same
Application: 15/889,857 →
Publication: US 2018/0161320
Dopamine D3 Receptor Antagonists
Application: 15/975,466 →
Publication: US 2018/0282318
Sustained-Release Buprenorphine Solutions
Application: 16/016,186 →
Publication: US 2019/0022085
Methods to Treat Opioid Use Disorder
Application: 16/016,250 →
Publication: US 2018/0360821
Syringe System
Application: 16/041,170 →
Publication: US 2019/0380909
Sustained Release Small Molecule Drug Formulation
Application: 16/044,259 →
Publication: US 2018/0325905
Therapeutic Compounds
Application: 16/073,429 →
Publication: US 2019/0040041
Methods for Treating Schizophrenia
Application: 16/101,298 →
Publication: US 2019/0015415
Intranasal Naloxone Compositions and Methods of Making and Using Same
Application: 16/110,440 →
Publication: US 2018/0360822
Dopamine D3 Receptor Antagonist Compounds
Application: 16/261,206 →
Publication: US 2019/0300514
Substituted 3,6-Diazabicyclo[3.2.0]Heptanes
Application: 16/292,110 →
Publication: US 2019/0194225
Sublingual and Buccal Film Compositions
Application: 16/439,530 →
Publication: US 2020/0030313
Sustained Delivery Formulations of Risperidone Compound
Application: 16/509,287 →
Publication: US 2020/0016270
Sustained Release Small Molecule Drug Formulation
Application: 16/511,210 →
Publication: US 2020/0046704
Injectable Flowable Composition Comprising Buprenorphine
Application: 16/693,726 →
Publication: US 2020/0089436
Sustained-Release Buprenorphine Formulations
Application: 62/199,778 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Notice of Grant of Security Interest in Patents and Trademarks Aug 7, 2015
From: INDIVIOR UK LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 036305/0397 →
Change of Name Dec 4, 2015
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 037218/0769 →
Notice of Grant of Security Interest in Patents Dec 10, 2015
From: INDIVIOR UK LIMITED (FKA RB PHARMACEUTICALS LIMITED)
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 037268/0233 →
Assignment of Assignor's Interest Jan 21, 2016
From: NASSER, AZMI
To: INDIVIOR UK LIMITED
Reel/Frame 037547/0252 →
Assignment of Assignor's Interest Jan 29, 2016
From: TOLMAR THERAPEUTICS INC.
To: INDIVIOR, INC.
Reel/Frame 037624/0933 →
Assignment of Assignor's Interest Jan 29, 2016
From: NASSER, AZMI
To: INDIVIOR UK LIMITED
Reel/Frame 037623/0217 →
Assignment of Assignor's Interest Jan 29, 2016
From: INDIVIOR INC.
To: INDIVIOR UK LIMITED
Reel/Frame 037618/0977 →
Corrective Assignment to Correct the Incorrect Serial No. 14/933,168 Previously Recorded at Reel: 037623 Frame: 0217. Assignor(S) Hereby Confirms the Assignment. Feb 11, 2016
From: NASSER, AZMI
To: INDIVIOR UK LIMITED
Reel/Frame 037793/0588 →
Assignment of Assignor's Interest Mar 4, 2016
From: GERK, PHILLIP M.
To: VIRGINIA COMMONWEALTH UNIVERSITY
Reel/Frame 037889/0306 →
Assignment of Assignor's Interest Feb 2, 2017
From: NORTON, RICHARD L.; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 041155/0056 →
Change of Name Feb 2, 2017
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 041591/0741 →
Assignment of Assignor's Interest Mar 27, 2017
From: BLANEY, EMMA LOUISE; MARTIN, BARRIE PHILLIP; NOWAK, THORSTEN; WATSON, MARTIN JOHN
To: C4X DISCOVERY LIMITED
Reel/Frame 041747/0984 →
Assignment of Assignor's Interest Sep 15, 2017
From: NORTON, RICHARD L.; WATKINS, ANDREW; ZHOU, MINGXING
To: RB PHARMACEUTICALS LIMITED
Reel/Frame 043603/0323 →
Change of Name Sep 15, 2017
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 044427/0717 →
Assignment of Assignor's Interest Oct 5, 2017
From: DURECT CORPORATION
To: INDIVIOR UK LIMITED
Reel/Frame 043801/0028 →
Change of Name Oct 11, 2017
From: RB PHARMACEUTICALS LIMITED
To: INDIVIOR UK LIMITED
Reel/Frame 044186/0092 →
Assignment of Assignor's Interest Dec 8, 2017
From: NASSER, AZMI
To: INDIVIOR UK LIMITED
Reel/Frame 044340/0830 →
Assignment of Assignor's Interest Feb 13, 2018
From: ZHOU, MINGXING; NORTON, RICHARD
To: INDIVIOR UK LIMITED
Reel/Frame 044912/0376 →
Assignment of Assignor's Interest Feb 22, 2018
From: MICHELI, FABRIZIO; CREMONESI, SUSANNA; SEMARARO, TERESA; TARSI, LUCA
To: APTUIT, SRL
Reel/Frame 045011/0479 →
Assignment of Assignor's Interest Feb 22, 2018
From: APTUIT, SRL
To: INDIVIOR UK LIMITED
Reel/Frame 045011/0483 →
Assignment of Assignor's Interest Jul 11, 2018
From: NASSER, AZMI
To: INDIVIOR UK LIMITED
Reel/Frame 046324/0935 →
Assignment of Assignor's Interest Dec 27, 2018
From: CREMONESI, SUSANNA; MICHELI, FABRIZIO; SEMERARO, TERESA; TARSI, LUCA
To: INDIVIOR UK LIMITED
Reel/Frame 047857/0963 →
Assignment of Assignor's Interest Jan 31, 2019
From: INDIVIOR, INC.
To: INDIVIOR UK LIMITED
Reel/Frame 048213/0918 →
Assignment of Assignor's Interest Jan 31, 2019
From: TOLMAR THERAPEUTICS, INC.
To: INDIVIOR, INC.
Reel/Frame 048213/0844 →
Assignment of Assignor's Interest Jan 31, 2019
From: DADEY, ERIC; WATKINS, ANDREW (DREW)
To: TOLMAR THERAPEUTICS, INC.
Reel/Frame 048213/0795 →